ARCHIVES

Genetic Test Identifies Patients With High Risk of Mortality

This article is from The Cancer Letter archive.

Vol. 35 No. 11 | November 30, 2012

Download PDF Visit The Full Archive

Related Articles

Ibrutinib Demonstrates 71% ORR In Phase Ib/II CLL and SLL Study

July 26, 2013

In Brief: Hutchinson Begins Prostate Cancer Study; Meyer Named GWU Medical Dean; Nurses Win VA Posts

April 9, 1993

Gilotrif Increases PFS Compared to Erlotinib In LUX-Lung 8 Phase III Head-to-Head Trial

October 31, 2014

Dugan Head ACCC, Yarbro President Elects; Amos Honored

March 18, 1983

DCT Programs Status Reported to Board

July 5, 1985

GOP Sweep Takes Out Two Old Friends, But Reagan Spoken say He Supports Cancer Program, NIH

November 14, 1980